Super-TDU (TFA) (1599441-71-0 free base)
CAS No.
Super-TDU (TFA) (1599441-71-0 free base) ( )
Catalog No. M30268 CAS No.
uper-TDU is an inhibitory peptide targeting YAP-TEADs interaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameSuper-TDU (TFA) (1599441-71-0 free base)
-
NoteResearch use only, not for human use.
-
Brief Descriptionuper-TDU is an inhibitory peptide targeting YAP-TEADs interaction.
-
Descriptionuper-TDU is an inhibitory peptide targeting YAP-TEADs interaction. (In Vitro):Super-TDU TFA downregulates expression of YAP-TEADs target genes CTGF, CYR61, and CDX2. Super-TDU TFA inhibited cell viability and colony formation of GC cell lines MGC-803, BGC-823, and HGC27.(In Vivo):Super-TDU TFA (intravenous Injection; 50 μg/kg or 500 μg/kg; per day ) markedly decreases the sizes, weights of tumors, and YAP target genes in a dose-dependent manner. Super-TDU TFA (Intravenous Injection; 250 μg/kg 500 μg/kg) has the t1/2α of 0.78 hours and 0.82 hours; the Cmax of 6.12 ng/mL and 13.3 ng/mL; the CL of 7.41 ml/min/kg and 7.72 ml/min/kg for 250 μg/kg and 500 μg/kg in mice, respectively.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight5394
-
Molecular FormulaC239H371N66O71S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Jiao S, et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 2014 Feb 10;25(2):166-80.
molnova catalog
related products
-
GW280264X
GW280264X is an inhibitor of ADAM17.
-
CH 5450
CH 5450 (Z-Ile-Glu-Pro-Phe-Ome) is a short peptide inhibitor of chymase in the human heart.
-
Rilmenidine Phosphat...
Rilmenidine Phosphate is a selective I(1) imidazoline receptor agonist, used to treat hypertension.